Latest Warnings Issued Over Quit Smoking Medicine Champix
Date: 4th June 2010
Federal health officials and Pfizer Incl., the manufacturer of the anti-smoking drug Champix have issued latest health warning on the medicine and with that the medication is likely to have a boxed warning generally given to medicines that are linked with unpleasant events and serious safety issues. The health officers of the federal health department have given latest public warning to champix, after being concerned over the increasing reports of enmity, changes of mood, suicidal behavior and dangerous skin reactions all facilitated by this quit smoking medicine.
According to sources, Pfizer Incl. and Health Canada have underlined specific side-effects of Champix such as seizures, loss of consciousness, dizziness et al. Altogether certain sources make it apparent that champix is associated with a couple of neuropsychiatric symptoms in patients that include emotional disturbance, depression, enmity, violence, feelings of self-harm and suicide.
The latest warning on Champix has also highlighted that patients using the medication have fallen prey to dangerous skin reactions including angioedema in which a specific type of swelling is developed beneath the skin. Sources reveal that patients having a history of psychiatric disorders as well as patients without a history of psychiatric disorders fall prey to the adverse effects of champix. According to Health Canada, the intake of alcohol is likely to enhance the health risk of patients consuming champix which is also known as chantix in United States.
Source: http://www.theglobeandmail.com/ |
